Tumor-shrinking effects of enfortumab vedotin between primary urothelial carcinoma and metastatic organs.
Saved in:
| Title: | Tumor-shrinking effects of enfortumab vedotin between primary urothelial carcinoma and metastatic organs. |
|---|---|
| Authors: | Ikarashi D; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan., Kawamura T; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan., Ogasawara K; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan., Arakawa Y; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan., Machida A; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan., Ito A; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan., Shiomi E; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan., Maekawa S; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan., Kato R; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan., Kanehira M; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan., Sugimura J; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan., Obara W; Department of Urology, Iwate Medical University School of Medicine, Iwate, Japan. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Jan 29; Vol. 14, pp. 1493922. Date of Electronic Publication: 2025 Jan 29 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2024.1493922 |
